ClinicalTrials.Veeva

Menu

Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting

T

Technion, Israel Institute of Technology

Status

Completed

Conditions

CABG
Revascularization

Treatments

Procedure: CABG

Study type

Observational

Funder types

Other

Identifiers

NCT06766084
RMC - 22-169

Details and patient eligibility

About

Retrospective study of adult patients with multivessel disease undergoing isolated coronary artery bypass grafting (CABG) in three centers between January 1st, 2009, and December 31st, 2023. Patients were grouped according to the revascularization strategy (total arterial revascularization vs. multiarterial grafting). Primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE).

Enrollment

7,878 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • isolated CABG

Exclusion criteria

  • single vessel CABG
  • CABG with utilization of only one arterial graft

Trial design

7,878 participants in 2 patient groups

multiarterial grafting
Treatment:
Procedure: CABG
total arterial revascularization
Treatment:
Procedure: CABG

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems